Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 47, Issue 9, 2012, Pages 1222-1228

  Van Der Beek, M T ^a   Laheij, A M G A ^a,b   Raber Durlacher, J E ^a,b   Von Dem Borne, P A ^a   Wolterbeek, R ^a   Van Der Blij De Brouwer, C S ^a   Van Loveren, C ^b   Claas, E C J ^a   Kroes, A C M ^a   De Soet, J J ^b   Vossen, A C T M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

herpesviruses; HSCT; HSV 1 resistance; mucositis; oral ulceration; stomatitis

Indexed keywords

ACICLOVIR; VIRUS DNA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; MOUTH ULCER; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS SHEDDING; VIRUS STRAIN;

DRUG RESISTANCE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; STOMATITIS; VIRAL LOAD;

EID: 84866004190     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.2     Document Type: Article

References (34)

1. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 1993; 20: 1493-1502.
2. Takahashi K, Soga Y, Murayama Y, Udagawa M, Nishimoto H, Sugiura Y et al. Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen. Support Care Cancer 2009; 18: 115-119.
3. Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT (HSCT)-results of a multicentre study. Bone Marrow Transplant 2010; 46: 727-732.
4. Woo SB, Sonis ST, Sonis AL. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients. Cancer 1990; 66: 2375-2379.
5. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612-1617. (Pubitemid 23249287)
6. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33-39. (Pubitemid 30096543)
7. Fanning SR, Rybicki L, Kalaycio M, Andresen S, Kuczkowski E, Pohlman B et al. Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol 2006; 135: 374-381. (Pubitemid 44484846)
8. Djuric M, Jankovic L, Jovanovic T, Pavlica D, Brkic S, Knezevic A et al. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. J Oral Pathol Med 2009; 38: 167-173.
9. Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R et al. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 2010; 18: 993-1006.
10. Schubert MM, Peterson DE, Flournoy N, Meyers JD, Truelove EL. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 1990; 70: 286-293. (Pubitemid 20313888)
11. Kameyama T, Sujaku C, Yamamoto S, Hwang CB, Shillitoe EJ. Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol 1988; 17: 478-481.
12. Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004; 42: 242-249. (Pubitemid 38082727)
13. Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N et al. HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol 2004; 30: 341-345. (Pubitemid 38649104)
14. Stranska R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, Weel JF et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005; 32: 7-18. (Pubitemid 39575009)
15. Lloid ME, Schubert MM, Myerson D, Bowden R, Meyers JD, Hackman RC. Cytomegalovirus infection of the tongue following marrow transplantation. Bone Marrow Transplant 1994; 14: 99-104. (Pubitemid 24228745)
16. Birek C, Patterson B, Maximiw WC, Minden MD. EBV and HSV infections in a patient who had undergone bone marrow transplantation: oral manifestations and diagnosis by in situ nucleic acid hybridization. Oral Surg Oral Med Oral Pathol 1989; 68: 612-617. (Pubitemid 19278840)
17. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng R et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003; 187: 1571-1580. (Pubitemid 36578963)
18. Lucht E, Brytting M, Bjerregaard L, Julander I, Linde A. Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. Clin Infect Dis 1998; 27: 137-141. (Pubitemid 28334432)
19. Kalpoe JS, van der Heiden PL, Vaessen N, Claas EC, Barge RM, Kroes AC. Comparable incidence and severity of cytomegalovirus infections following T celldepleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning. Bone Marrow Transplant 2007; 40: 137-143. (Pubitemid 47046211)
20. Barge RM, Brouwer RE, Beersma MF, Starrenburg CW, Zwinderman AH, Hale G et al. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome. Bone Marrow Transplant 2001; 27: 1053-1058. (Pubitemid 32591188)
21. Barge RM, Osanto S, Marijt WA, Starrenburg CW, Fibbe WE, Nortier JW et al. Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors. Exp Hematol 2003; 31: 865-872. (Pubitemid 37211370)
22. World Health Organization. Handbook for reporting results of cancer treatment. World Health Organization: Geneva, pp. 1979, 16-17.
23. Kalpoe JS, Kroes AC, de Jong MD, Schinkel J, de Brouwer CS, Beersma MF et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004; 42: 1498-1504. (Pubitemid 38500787)
24. Niesters HG, van EJ, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38: 712-715. (Pubitemid 30082668)
25. van der Beek MT, Claas EC, van der Blij-de Brouwer CS, Morfin F, Rusman LG, Kroes ACM et al. Rapid susceptibility testing for Herpes Simplex Virus type 1; Antiviral Res (submitted).
26. Gaudreau A, Hill E, Balfour Jr HH, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998; 178: 297-303. (Pubitemid 28347909)
27. Styczynski J, Reusser P, Einsele H, de la Camara R, Cordonnier C, Ward KN et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 2009; 43: 757-770.
28. Ruping MJ, Keulertz C, Vehreschild JJ, Lovenich H, Sohngen D, Wieland U et al. Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT. Support Care Cancer 2010; 19: 1211-1216.
29. Andrei G, Balzarini J, Fiten P, De CE, Opdenakker G, Snoeck R. Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin. J Virol 2005; 79: 5863-5869. (Pubitemid 40548256)
30. Duan R, de Vries RD, van Dun JM, van Loenen FB, Osterhaus AD, Remeijer L et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009; 200: 1402-1414.
31. Schmit I, Boivin G. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed. J Infect Dis 1999; 180: 487-490. (Pubitemid 30256332)
32. Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR et al. Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol 1985; 21: 353-356. (Pubitemid 15168644)
33. Mendoza N, Diamantis M, Arora A, Bartlett B, Gewirtzman A, Tremaine AM et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol 2008; 9: 295-305.
34. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 2010; 34: 405-417.